Related Experiment Videos
Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours
J Bartkova1, J Falck, E Rajpert-De Meyts
1Danish Cancer Society, Institute of Cancer Biology, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark.
Abstract:
Chk2 is a transducer of DNA damage signals and a tumour suppressor whose germ-line mutations predispose to diverse tumour types. Unlike its downstream targets such as the p53 tumour suppressor, the expression patterns of Chk2 in tissues and tumours remain unknown. As DNA breaks occur commonly during gametogenesis, and p53 is wild-type and overexpressed in testicular cancer, we examined abundance and localisation of the Chk2 protein during normal development of human testes, and at various stages of germ-cell tumour (GCT) pathogenesis. Our results show that Chk2 is abundant in foetal germ cells and adult spermatogonia, yet only weakly expressed or lacking during the meiotic and later stages of spermatogenesis. High levels of Chk2 are detected in the majority of GCTs including all pre-invasive carcinoma-in-situ lesions, contrary to variable expression and even lack of Chk2 in subsets of invasive GCTs and some teratoma structures, respectively. Together with our analyses of cell culture models, these results indicate that downmodulation or lack of Chk2 is not simply attributable to quiescence or differentiation, they suggest a role for Chk2 in mitotic rather than meiotic divisions, support the concept of foetal origin of GCTs, and have implications for protein-based screening for tumour-associated aberrations of Chk2.
Insights
Checkpoint kinase 2 (Chk2) is crucial for DNA damage response. This study reveals Chk2
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Checkpoint kinase 2 (Chk2) acts as a DNA damage signal transducer and tumor suppressor.
- Germline mutations in Chk2 are linked to various cancer types.
- Expression patterns of Chk2 in normal tissues and tumors are largely unknown.
Purpose of the Study:
- To investigate the expression and localization of Chk2 protein during normal human testicular development.
- To analyze Chk2 protein levels throughout the pathogenesis of germ cell tumors (GCTs).
- To explore the functional role of Chk2 in spermatogenesis and GCT development.
Main Methods:
- Immunohistochemical analysis of Chk2 protein in human testicular tissue samples at different developmental stages.
- Examination of Chk2 expression in various types of germ cell tumors (GCTs), including pre-invasive lesions.
- In vitro studies using cell culture models to assess Chk2 modulation in response to differentiation and quiescence.
Main Results:
- Chk2 protein is highly abundant in fetal germ cells and adult spermatogonia.
- Chk2 expression is significantly reduced or absent during later stages of spermatogenesis (meiotic and post-meiotic).
- Elevated Chk2 levels are observed in most GCTs, including carcinoma in situ, but show variable expression or loss in invasive GCTs and teratomas.
Conclusions:
- Chk2 downmodulation is not solely due to differentiation or quiescence.
- Chk2 appears to play a role in mitotic rather than meiotic cell divisions.
- Findings support a fetal origin for GCTs and suggest potential for Chk2-based tumor screening.